{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:00:05Z","timestamp":1793397605616,"version":"4.5.0"},"reference-count":60,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi251459-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>People with HIV experience higher rates of frailty and falls than age-matched people without HIV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251459-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To estimate the life-years lost, quality-adjusted life-years (QALYs) lost, and costs attributable to prefrailty, frailty, and falls among people with HIV and viral suppression in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251459-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This decision analytic modeling study used the Frailty Policy Model, a microsimulation model, to project lifetime health and cost outcomes associated with frailty and falls among people with HIV in the United States. The model simulated individuals representing people with HIV and viral suppression in the United States aged 40 years and older in 2022, and results were scaled to the estimated population size of 521\u202f994 individuals. Simulation model parameters were drawn from the Advancing Clinical Therapeutics Globally (ACTG) A5322 Study, the Multicenter AIDS Cohort Study (MACS)\/Women\u2019s Interagency HIV Study (WIHS) Combined Cohort Study, and published literature. Data analysis was conducted from November 2023 to October 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251459-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Prefrailty, frailty, and falls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251459-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Life-years lost, QALYs lost, and costs attributable to prefrailty, frailty, and falls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251459-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The simulated individuals representing people with HIV and viral suppression had a mean (SD) age of 56 (10) years; 25% were female; 41% had prefrailty, and 7% had frailty. The model projected that the simulated individuals would have a remaining life expectancy of 20.3 (95% uncertainty interval [UI], 19.7-20.8) years, with a mean of 12.0 (95% UI, 11.2-12.8) years with prefrailty or frailty and 10.1 (95% UI, 8.2-12.1) falls per person. Scaled to the population level, the model projected that there would be 31\u202f000 (95% UI, 16\u202f000-57\u202f000) life-years lost, 214\u202f000 (95% UI, 130\u202f000-292\u202f000) QALYs lost, and $5.0 (95% UI, $3.2-$7.2) billion in lifetime costs attributable to prefrailty. There would be 1\u202f352\u202f000 (95% UI, 84\u202f000-3\u202f336\u202f000) life-years lost, 1\u202f091\u202f000 (95% UI, 209\u202f000-2\u202f500\u202f000) QALYs lost, and $8.8 (95% UI, $4.7-$14.2) billion in lifetime costs attributable to frailty. There would be 183\u202f000 (95% UI, 120\u202f000-266\u202f000) life-years lost, 141\u202f000 (95% UI, 94\u202f000-198\u202f000) QALYs lost, and $3.4 (95% UI, $2.2-$4.8) billion attributable to falls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251459-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this decision analytic modeling study of frailty and falls among people with HIV and viral suppression, the lifetime QALYs lost and costs attributable to frailty and falls were substantial. These findings highlight the potential clinical and economic benefits that could result from interventions to identify, prevent, and treat frailty and falls among people with HIV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.54809","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:00:25Z","timestamp":1769011225000},"page":"e2554809","source":"Crossref","is-referenced-by-count":1,"title":["Modeled Health and Economic Burden of Frailty and Falls Among Adults With HIV"],"prefix":"10.1001","volume":"9","author":[{"given":"Karen C.","family":"Smith","sequence":"first","affiliation":[{"name":"Orthopedic and Arthritis Center for Outcomes Research (OrACORe), Department of Orthopedic Surgery, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathryn","family":"Brown","sequence":"additional","affiliation":[{"name":"Orthopedic and Arthritis Center for Outcomes Research (OrACORe), Department of Orthopedic Surgery, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily P.","family":"Hyle","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Medical Practice Evaluation Center (MPEC), Massachusetts General Hospital, Boston"},{"name":"Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhaneh","family":"Zafarnejad","sequence":"additional","affiliation":[{"name":"Orthopedic and Arthritis Center for Outcomes Research (OrACORe), Department of Orthopedic Surgery, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd T.","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Freedberg","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Medical Practice Evaluation Center (MPEC), Massachusetts General Hospital, Boston"},{"name":"Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine M.","family":"Erlandson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of Colorado\u2013Anschutz Medical Campus, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Losina","sequence":"additional","affiliation":[{"name":"Orthopedic and Arthritis Center for Outcomes Research (OrACORe), Department of Orthopedic Surgery, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"issue":"6","key":"zoi251459r1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.7954","article-title":"Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000-2016.","volume":"3","author":"Marcus","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"zoi251459r2","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1016\/S2352-3018(23)00028-0","article-title":"Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies.","volume":"10","author":"Trickey","year":"2023","journal-title":"Lancet HIV"},{"issue":"1","key":"zoi251459r3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/jama.2019.19775","article-title":"Comorbidities in persons with HIV: the lingering challenge.","volume":"323","author":"Lerner","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"zoi251459r4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.8023","article-title":"What it means to age with HIV infection: years gained are not comorbidity free.","volume":"3","author":"Collins","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi251459r5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/COH.0000000000000677","article-title":"Frailty: the current challenge for aging people with HIV.","volume":"16","author":"Falutz","year":"2021","journal-title":"Curr Opin HIV AIDS"},{"issue":"8","key":"zoi251459r6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.27584","article-title":"Aging-related comorbidity burden among women and men with or at-risk for HIV in the US, 2008-2019.","volume":"6","author":"Collins","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi251459r7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004325","article-title":"The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: a modeling study.","volume":"21","author":"Althoff","year":"2024","journal-title":"PLoS Med"},{"issue":"1","key":"zoi251459r8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11904-018-0372-5","article-title":"Inflammation strikes again: frailty and HIV.","volume":"15","author":"Fukui","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"10279","key":"zoi251459r9","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/S0140-6736(21)00395-0","article-title":"Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses.","volume":"397","author":"Sullivan","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"zoi251459r10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/QAD.0000000000001721","article-title":"Cancer burden attributable to cigarette smoking among HIV-infected people in North America.","volume":"32","author":"Altekruse","year":"2018","journal-title":"AIDS"},{"issue":"9","key":"zoi251459r11","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/jbmr.3183","article-title":"Immediate initiation of antiretroviral therapy for HIV infection accelerates bone loss relative to deferring therapy: findings from the START Bone Mineral Density Substudy, a randomized trial.","volume":"32","author":"Hoy","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"11","key":"zoi251459r12","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/gerona\/62.11.1279","article-title":"HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty.","volume":"62","author":"Desquilbet","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"zoi251459r13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/QAD.0000000000000910","article-title":"HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls.","volume":"30","author":"Kooij","year":"2016","journal-title":"AIDS"},{"issue":"2","key":"zoi251459r14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/gerona\/glt148","article-title":"Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men.","volume":"69","author":"Althoff","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"zoi251459r15","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype.","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"zoi251459r16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s11904-016-0334-8","article-title":"Frailty in HIV: epidemiology, biology, measurement, interventions, and research needs.","volume":"13","author":"Piggott","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"zoi251459r17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.14283\/jfa.2016.79","article-title":"Frailty and constellations of factors in aging HIV-infected and uninfected women\u2014the Women\u2019s Interagency HIV Study.","volume":"5","author":"Gustafson","year":"2016","journal-title":"J Frailty Aging"},{"issue":"1","key":"zoi251459r18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12877-022-03719-8","article-title":"Effects of frailty, geriatric syndromes, and comorbidity on mortality and quality of life in older adults with HIV.","volume":"23","author":"Bra\u00f1as","year":"2023","journal-title":"BMC Geriatr"},{"issue":"3","key":"zoi251459r19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/gerona\/glw142","article-title":"Frailty and cause-specific hospitalization among persons aging with HIV infection and injection drug use.","volume":"72","author":"Piggott","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"zoi251459r20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3851\/IMP3286","article-title":"Frailty as a predictor of falls in HIV-infected and uninfected women.","volume":"24","author":"Sharma","year":"2019","journal-title":"Antivir Ther"},{"issue":"3","key":"zoi251459r21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/QAD.0000000000002082","article-title":"Frailty predicts fractures among women with and at-risk for HIV.","volume":"33","author":"Sharma","year":"2019","journal-title":"AIDS"},{"issue":"2","key":"zoi251459r22","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1097\/QAI.0000000000002651","article-title":"High frequency of recurrent falls among prefrail and frail women with and without HIV.","volume":"87","author":"Sharma","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"16","key":"zoi251459r23","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1097\/QAD.0000000000001613","article-title":"Frailty is strongly associated with increased risk of recurrent falls among older HIV-infected adults.","volume":"31","author":"Tassiopoulos","year":"2017","journal-title":"AIDS"},{"issue":"4","key":"zoi251459r24","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/QAI.0b013e3182716e38","article-title":"Risk factors for falls in HIV-infected persons.","volume":"61","author":"Erlandson","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"zoi251459r25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/109019818401100101","article-title":"The health belief model: a decade later.","volume":"11","author":"Janz","year":"1984","journal-title":"Health Educ Q"},{"issue":"4","key":"zoi251459r26","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.3390\/ijerph19041938","article-title":"Older adults\u2019 perceptions and recommendations regarding a falls prevention self-management plan template based on the health belief model: a mixed-methods study.","volume":"19","author":"Vincenzo","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"zoi251459r32","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/infdis\/jiaa010","article-title":"Frailty is associated with mortality and incident comorbidity among middle-aged human immunodeficiency virus (HIV)-positive and HIV-negative participants.","volume":"222","author":"Verheij","year":"2020","journal-title":"J Infect Dis"},{"issue":"11","key":"zoi251459r33","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s00198-007-0429-6","article-title":"Excess mortality following hip fracture: the role of underlying health status.","volume":"18","author":"Tosteson","year":"2007","journal-title":"Osteoporos Int"},{"issue":"3","key":"zoi251459r34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1177\/0272989X221141454","article-title":"Estimates of quality-adjusted life-year loss for injuries in the United States.","volume":"43","author":"Raich","year":"2023","journal-title":"Med Decis Making"},{"issue":"4","key":"zoi251459r35","doi-asserted-by":"publisher","first-page":"463","DOI":"10.7326\/M22-2626","article-title":"Incremental health care costs of self-reported functional impairments and phenotypic frailty in community-dwelling older adults: a prospective cohort study.","volume":"176","author":"Ensrud","year":"2023","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi251459r36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1136\/injuryprev-2019-043544","article-title":"Average medical cost of fatal and non-fatal injuries by type in the USA.","volume":"27","author":"Peterson","year":"2021","journal-title":"Inj Prev"},{"issue":"4","key":"zoi251459r38","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1097\/QAI.0000000000002074","article-title":"Risk factors for falls, falls with injury, and falls with fracture among older men with or at risk of HIV infection.","volume":"81","author":"Erlandson","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"zoi251459r39","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1111\/jgs.18304","article-title":"Assessing the contributions of modifiable risk factors to serious falls and fragility fractures among older persons living with HIV.","volume":"71","author":"Womack","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"zoi251459r40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/QAI.0000000000002100","article-title":"Detrimental effects of psychotropic medications differ by sex in aging people with HIV.","volume":"82","author":"Mathur","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"zoi251459r41","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/cid\/ciy1101","article-title":"Frailty is an independent risk factor for mortality, cardiovascular disease, bone disease, and diabetes among aging adults with human immunodeficiency virus.","volume":"69","author":"Kelly","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"8","key":"zoi251459r42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0290113","article-title":"The association between all-cause mortality and HIV acquisition risk groups in the United States, 2001-2014.","volume":"18","author":"Shebl","year":"2023","journal-title":"PLoS One"},{"issue":"4","key":"zoi251459r44","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1377\/hlthaff.2020.01869","article-title":"Urgent care centers deter some emergency department visits but, on net, increase spending.","volume":"40","author":"Wang","year":"2021","journal-title":"Health Aff (Millwood)"},{"issue":"2","key":"zoi251459r45","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/ageing\/aft115","article-title":"Cross-national disparities in sex differences in life expectancy with and without frailty.","volume":"43","author":"Romero-Ortuno","year":"2014","journal-title":"Age Ageing"},{"issue":"3","key":"zoi251459r46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150939","article-title":"Falls and fall-related injuries among community-dwelling adults in the United States.","volume":"11","author":"Verma","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"zoi251459r47","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11904-021-00554-1","article-title":"Frailty and HIV: moving from characterization to intervention.","volume":"18","author":"Erlandson","year":"2021","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"6","key":"zoi251459r48","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1056\/NEJMra2301292","article-title":"Frailty in older adults.","volume":"391","author":"Kim","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi251459r49","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/gerona\/glu099","article-title":"A physical activity intervention to treat the frailty syndrome in older persons-results from the LIFE-P study.","volume":"70","author":"Cesari","year":"2015","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"16","key":"zoi251459r50","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1097\/QAD.0000000000001984","article-title":"Physical function improvements with moderate or high-intensity exercise among older adults with or without HIV infection.","volume":"32","author":"Erlandson","year":"2018","journal-title":"AIDS"},{"issue":"21","key":"zoi251459r51","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1001\/jama.2019.5795","article-title":"Effect of a home-based exercise program on subsequent falls among community-dwelling high-risk older adults after a fall: a randomized clinical trial.","volume":"321","author":"Liu-Ambrose","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"zoi251459r52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jama.2024.8481","article-title":"Interventions to prevent falls in community-dwelling older adults: US Preventive Services Task Force recommendation statement.","volume":"332","author":"Nicholson","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"zoi251459r53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/15394492241238956","article-title":"A fall prevention feasibility trial for people with HIV and alcohol use.","volume":"45","author":"Gill","year":"2025","journal-title":"OTJR (Thorofare N J)"},{"issue":"1","key":"zoi251459r54","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12879-017-2342-8","article-title":"Effectiveness of progressive resistive exercise (PRE) in the context of HIV: systematic review and meta-analysis using the Cochrane Collaboration protocol.","volume":"17","author":"O\u2019Brien","year":"2017","journal-title":"BMC Infect Dis"},{"key":"zoi251459r55","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12879-016-1478-2","article-title":"Effectiveness of aerobic exercise for adults living with HIV: systematic review and meta-analysis using the Cochrane Collaboration protocol.","volume":"16","author":"O\u2019Brien","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"6","key":"zoi251459r56","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1093\/cid\/ciad782","article-title":"Polypharmacy is associated with slow gait speed and recurrent falls in older people with HIV.","volume":"78","author":"Kosana","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"4","key":"zoi251459r57","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/COH.0000000000000943","article-title":"Frailty in people with HIV: a geriatric syndrome approach to aging with HIV.","volume":"20","author":"Zhabokritsky","year":"2025","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"zoi251459r58","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1186\/s12877-022-03477-7","article-title":"Frailty in older people living with HIV: current status and clinical management.","volume":"22","author":"Kehler","year":"2022","journal-title":"BMC Geriatr"},{"issue":"1","key":"zoi251459r59","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/ageing\/aft160","article-title":"The frailty phenotype and the Frailty Index: different instruments for different purposes.","volume":"43","author":"Cesari","year":"2014","journal-title":"Age Ageing"},{"issue":"4","key":"zoi251459r60","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1377\/hlthaff.2021.01793","article-title":"The association of HIV with health care spending and use among Medicare beneficiaries.","volume":"41","author":"Figueroa","year":"2022","journal-title":"Health Aff (Millwood)"},{"key":"zoi251459r27","unstructured":"Centers for Disease Control and Prevention. HIV surveillance report: diagnoses, deaths, and prevalence of HIV in the United States and 6 territories and freely associated states, 2022. May 21, 2024. Accessed December 30, 2024. https:\/\/www.cdc.gov\/hiv-data\/nhss\/hiv-diagnoses-deaths-prevalence.html"},{"key":"zoi251459r28","unstructured":"Centers for Disease Control and Prevention (CDC). HIV surveillance supplemental report: monitoring selected national HIV prevention and care objectives by using HIV surveillance data\u2014United States and 6 territories and freely associated states, 2022. May 21, 2024. Accessed December 30, 2024. https:\/\/www.cdc.gov\/hiv-data\/nhss\/national-hiv-prevention-and-care-outcomes.html"},{"key":"zoi251459r29","unstructured":"ACTG Network. A5322: long-term follow-up of older HIV-infected adults in the ACTG: addressing issues of Aging, HIV Infection and Inflammation (HAILO). Accessed November 15, 2024. https:\/\/actgnetwork.org\/clinical-trial\/a5322-long-term-follow-up-of-older-hiv-infected-adults-in-the-actg-addressing-issues-of-aging-hiv-infection-and-inflammation-hailo-2\/"},{"key":"zoi251459r30","unstructured":"National Heart, Lung, and Blood Institute. MACS\/WIHS Combined Cohort Study. Accessed November 15, 2024. https:\/\/www.nhlbi.nih.gov\/science\/macswihs-combined-cohort-study"},{"key":"zoi251459r31","unstructured":"Massachusetts General Hospital Medical Practice Evaluation Center. CEPAC Model. Accessed November 15, 2024. https:\/\/mpec.massgeneral.org\/cepac-model\/"},{"key":"zoi251459r37","unstructured":"Hansen? D, Pelizzari? PM, Pyenson? BS. Medicare cost of osteoporotic fractures: 2021 updated report. Milliman Research Report. March 29, 2021. Accessed December 9, 2025. https:\/\/www.milliman.com\/en\/insight\/medicare-cost-of-osteoporotic-fractures-2021-updated-report"},{"key":"zoi251459r43","unstructured":"Centers for Medicare & Medicaid Services. National Health Expenditure Accounts (NHEA): personal health care (PCE) expenditure deflator. Accessed January 27, 2025. https:\/\/www.cms.gov\/Research-Statistics-Data-and-Systems\/Statistics-Trends-and-Reports\/NationalHealthExpendData\/NationalHealthAccountsHistorical"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2844129\/smith_2026_oi_251459_1768335157.36886.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:00:27Z","timestamp":1769011227000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2844129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.54809","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]}}}